Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 6
2005 5
2006 8
2007 7
2008 9
2009 6
2010 2
2011 3
2012 5
2013 3
2014 5
2015 7
2016 5
2017 6
2018 7
2019 5
2020 6
2021 6
2022 6
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Diabetic dyslipidaemia.
Soran H, Schofield JD, Adam S, Durrington PN. Soran H, et al. Among authors: durrington pn. Curr Opin Lipidol. 2016 Aug;27(4):313-22. doi: 10.1097/MOL.0000000000000318. Curr Opin Lipidol. 2016. PMID: 27213628 Review.
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators. Colhoun HM, et al. Among authors: durrington pn. Lancet. 2004 Aug 21-27;364(9435):685-96. doi: 10.1016/S0140-6736(04)16895-5. Lancet. 2004. PMID: 15325833 Clinical Trial.
Lipoprotein (a) in familial hypercholesterolaemia.
Durrington PN, Bashir B, Bhatnagar D, Soran H. Durrington PN, et al. Curr Opin Lipidol. 2022 Aug 1;33(4):257-263. doi: 10.1097/MOL.0000000000000839. Curr Opin Lipidol. 2022. PMID: 35942820 Review.
Paraoxonase 1 and atherosclerosis.
Durrington PN, Bashir B, Soran H. Durrington PN, et al. Front Cardiovasc Med. 2023 Feb 16;10:1065967. doi: 10.3389/fcvm.2023.1065967. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36873390 Free PMC article. Review.
HDL functionality.
Soran H, Hama S, Yadav R, Durrington PN. Soran H, et al. Among authors: durrington pn. Curr Opin Lipidol. 2012 Aug;23(4):353-66. doi: 10.1097/MOL.0b013e328355ca25. Curr Opin Lipidol. 2012. PMID: 22732521 Review.
Antioxidant properties of HDL.
Soran H, Schofield JD, Durrington PN. Soran H, et al. Among authors: durrington pn. Front Pharmacol. 2015 Oct 16;6:222. doi: 10.3389/fphar.2015.00222. eCollection 2015. Front Pharmacol. 2015. PMID: 26528181 Free PMC article. Review.
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options.
Bashir B, Ho JH, Downie P, Hamilton P, Ferns G, Datta D, Cegla J, Wierzbicki AS, Dawson C, Jenkinson F, Delaney H, Mansfield M, Teoh Y, Miedzybrodzka Z, Haso H, Durrington PN, Soran H. Bashir B, et al. Among authors: durrington pn. Metabolites. 2023 Apr 30;13(5):621. doi: 10.3390/metabo13050621. Metabolites. 2023. PMID: 37233662 Free PMC article. Review.
Editorial introduction.
Durrington PN. Durrington PN. Curr Opin Lipidol. 2017 Aug;28(4):v. doi: 10.1097/MOL.0000000000000439. Curr Opin Lipidol. 2017. PMID: 28700378 No abstract available.
Lipoprotein (a): gene genie.
Durrington PN, Schofield JD, Siahmansur T, Soran H. Durrington PN, et al. Curr Opin Lipidol. 2014 Aug;25(4):289-96. doi: 10.1097/MOL.0000000000000096. Curr Opin Lipidol. 2014. PMID: 24977982 Review.
107 results